1077 Preclinical and IND-enabling studies of TXN10128, an ENPP1 inhibitor, for clinical evaluation in patients with solid tumor

• Jun Yong Choi,
• Shin-Yeong Kim,
• Sun Woo Lee,
• Hye Lim Choi,
• Hyang Ji Chae,
• Eun Kyung Yoo,
• Chang Won Min,
• Junghwan Choi,
• Bo Kyung Sun,
• Eun Young Kwak,
• Yongyea Park,
• Sungjoon Kim,
• JongRan Kim,
• Jong Heun Lee,
• Chan Sun Park

Affiliations

Jun Yong Choi

1Txinno Bioscience Inc., Yongin, Gyunggi-do, Republic of Korea

Shin-Yeong Kim

1Txinno Bioscience Inc., Yongin, Gyunggi-do, Republic of Korea

Sun Woo Lee

1Txinno Bioscience Inc., Yongin, Gyunggi-do, Republic of Korea

Hye Lim Choi

1Txinno Bioscience Inc., Yongin, Gyunggi-do, Republic of Korea

Hyang Ji Chae

1Txinno Bioscience Inc., Yongin, Gyunggi-do, Republic of Korea

Eun Kyung Yoo

1Txinno Bioscience Inc., Yongin, Gyunggi-do, Republic of Korea

Chang Won Min

1Txinno Bioscience Inc., Yongin, Gyunggi-do, Republic of Korea

Junghwan Choi

1Txinno Bioscience Inc., Yongin, Gyunggi-do, Republic of Korea

Bo Kyung Sun

1Txinno Bioscience Inc., Yongin, Gyunggi-do, Republic of Korea

Eun Young Kwak

1Txinno Bioscience Inc., Yongin, Gyunggi-do, Republic of Korea

Yongyea Park

1Txinno Bioscience Inc., Yongin, Gyunggi-do, Republic of Korea

Sungjoon Kim

1Txinno Bioscience Inc., Yongin, Gyunggi-do, Republic of Korea

JongRan Kim

2IGNITE clinical development, Anyang, Gyunggi-do, Republic of Korea

Jong Heun Lee

1Txinno Bioscience Inc., Yongin, Gyunggi-do, Republic of Korea

Chan Sun Park

1Txinno Bioscience Inc., Yongin, Gyunggi-do, Republic of Korea